Related references
Note: Only part of the references are listed.High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes Subanalysis of the Japan Diabetes Complications Study
Hirohito Sone et al.
DIABETES CARE (2012)
Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
Jennifer A. Hirst et al.
DIABETES CARE (2012)
Type 2 Diabetes: An Epidemic Requiring Global Attention and Urgent Action
William H. Herman et al.
DIABETES CARE (2012)
Cellular and molecular effects of resveratrol in health and disease
Wei Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age
Simonetta Genovesi et al.
JOURNAL OF HYPERTENSION (2012)
Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats
Xavier L. Louis et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Jill P. Crandall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice
Gyeong-Min Do et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Jayesh Kumar Bhatt et al.
NUTRITION RESEARCH (2012)
The worldwide diabetes epidemic
David W. Lam et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2012)
Anti-diabetic effects of resveratrol
Tomasz Szkudelski et al.
RESVERATROL AND HEALTH (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway
Sijo J. Thandapilly et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Resveratrol and health - A comprehensive review of human clinical trials
James M. Smoliga et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Antidiabetic Activity of Resveratrol, a known SIRT1 Activator in a Genetic Model for Type-2 Diabetes
Sameer Sharma et al.
PHYTOTHERAPY RESEARCH (2011)
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Ole Vang et al.
PLOS ONE (2011)
Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure
Sijo J. Thandapilly et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Glycemic Control and Complications in Type 2 Diabetes Mellitus
Mark Stolar
AMERICAN JOURNAL OF MEDICINE (2010)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Resveratrol: A Multifunctional Cytoprotective Molecule
Bela Juhasz et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Current views on type 2 diabetes
Yi Lin et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Central Administration of Resveratrol Improves Diet-Induced Diabetes
Giorgio Ramadori et al.
ENDOCRINOLOGY (2009)
Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study
Akhtar Hussain et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2007)
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol
Danijel Juric et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
Approved IFCC reference method for the measurement of HbA(1c) in human blood
JO Jeppsson et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
Share Paper
